Published in Bull Mem Soc Fr Ophtalmol on January 01, 1982
Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol (2001) 5.62
Studies on the permeability of the blood-retinal barrier. IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier. Exp Eye Res (1966) 1.95
Studies on the permeability of the blood-retinal barrier. I. On the existence, development, and site of a blood-retinal barrier. Br J Ophthalmol (1966) 1.90
The active transport of fluorescein by the retinal vessels and the retina. J Physiol (1967) 1.80
Iris crystals and hypergammaglobulinemia. Am J Ophthalmol (1990) 1.76
Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol (1980) 1.69
High incidence of sympathetic ophthalmia after contact and noncontact neodymium:YAG cyclotherapy. Ophthalmology (1992) 1.64
Progression of diabetic retinopathy after endophthalmitis. Ophthalmology (1999) 1.48
Iris crystals in Fuch heterochromic iridocyclitis. Arch Ophthalmol (1998) 1.47
Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol (2005) 1.42
Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol (1988) 1.27
Iris crystals in chronic iridocyclitis. Br J Ophthalmol (1993) 1.26
Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study. Br J Ophthalmol (1994) 1.20
Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol (2008) 1.16
Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus. Arch Ophthalmol (1980) 1.16
The blood-retinal barriers. Doc Ophthalmol (1976) 1.12
Twenty cases of sympathetic ophthalmia. Br J Ophthalmol (1989) 1.08
Effect of melanin on traumatic hyphema in rabbits. Arch Ophthalmol (1999) 1.07
Studies on retinal blood flow. II. Diabetic retinopathy. Arch Ophthalmol (1978) 1.07
L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity. Vision Res (1999) 1.06
Prevalence and surgical complications of pseudoexfoliation syndrome in Portuguese patients with senile cataract. J Cataract Refract Surg (1996) 1.06
Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide (2000) 1.03
Quantification of diabetic macular edema. Arch Ophthalmol (1987) 1.02
Fuchs' heterochromic iridocyclitis in blacks. Arch Ophthalmol (1988) 1.01
Ocular manifestations of Whipple disease: an atypical presentation. Arch Ophthalmol (1998) 1.01
Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea (1993) 1.00
Bilateral cytomegalovirus panuveitis after high-dose corticosteroid therapy. Am J Ophthalmol (1979) 0.99
Early detection of retinal involvement in diabetes by vitreous fluorophotometry. Ophthalmology (1979) 0.98
Birdshot retinochoroidopathy. Arch Ophthalmol (1984) 0.98
Detection of early retinal changes in diabetes by vitreous fluorophotometry. Diabetes (1979) 0.97
Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes (1985) 0.96
Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy. Arch Ophthalmol (1985) 0.95
Breakdown of the blood-retinal barriers and cystoid macular edema. Surv Ophthalmol (1984) 0.95
Pathophysiology of diabetic retinopathy. Br J Ophthalmol (1978) 0.95
One-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative retinopathy. Arch Ophthalmol (2001) 0.94
Diabetic retinopathy. Human and experimental studies. Trans Ophthalmol Soc U K (1972) 0.93
Outward transport of fluorescein from the vitreous in normal human subjects. Arch Ophthalmol (1983) 0.93
Multifocal choroiditis. Int Ophthalmol Clin (1990) 0.93
Iatrogenic choroidal neovascularization in sickle cell retinopathy. Ophthalmology (1986) 0.92
Vitreous fluorophotometry for clinical research. II. Method of data acquisition and processing. Arch Ophthalmol (1983) 0.92
Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis. Invest Ophthalmol Vis Sci (1981) 0.92
Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer. Arch Ophthalmol (1983) 0.92
Studies on the permeability of the blood-retinal barrier. 3. Breakdown of the blood-retinal barrier by circulatory disturbances. Br J Ophthalmol (1966) 0.92
Sympathetic ophthalmia following neodymium:YAG cyclotherapy. Ophthalmic Surg (1989) 0.92
Preliminary study of a new intraocular method in the diagnosis and treatment of Propionibacterium acnes endophthalmitis following cataract extraction. Ophthalmic Surg (1993) 0.91
Inflammatory pseudohistoplasmosis. Ann Ophthalmol (1985) 0.90
Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Arch Ophthalmol (2000) 0.90
Blood-retina barrier in acute retinal branch vein occlusion. Graefes Arch Clin Exp Ophthalmol (1995) 0.90
Acute endogenous endophthalmitis due to Bartonella henselae. Clin Infect Dis (2001) 0.89
Ultrastructural mechanisms of breakdown of the blood-retina barrier. J Pathol Bacteriol (1967) 0.89
Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous. Arch Ophthalmol (1999) 0.88
Anterior granulomatous uveitis in patients with multiple sclerosis. Ophthalmology (1991) 0.88
Effect of cyclosporin-A on the blood--retinal barrier permeability in streptozotocin-induced diabetes. Mediators Inflamm (2000) 0.87
Diagnosing acute retrobulbar neuritis by vitreous fluorophotometry. Am J Ophthalmol (1981) 0.87
Mitomycin as adjunct therapy in correcting iatrogenic punctal stenosis. Ophthalmic Surg (1993) 0.87
Studies on the permeability of the blood-retinal barrier. II. Breakdown of the blood-retinal barrier by injury. Br J Ophthalmol (1966) 0.86
Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis. Invest Ophthalmol Vis Sci (1996) 0.86
Corneal dellen in the limbal approach to rectus muscle surgery. Br J Ophthalmol (1975) 0.85
Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study. Graefes Arch Clin Exp Ophthalmol (2007) 0.85
Vitreous fluorophotometry in the alloxan- and streptozocin-treated rat. Arch Ophthalmol (1982) 0.84
Studies on the effects of osmotically active substances on the circulation and structure of the retina. I. Observations in vivo. Invest Ophthalmol (1967) 0.84
Vitreous fluorophotometry in pars planitis. Am J Ophthalmol (1983) 0.84
Alteration of the blood-retinal barrier by sodium iodate: kinetic vitreous fluorophotometry and horseradish peroxidase tracer studies. Exp Eye Res (1982) 0.84
Studies on the technique of vitreous fluorophotometry. Invest Ophthalmol Vis Sci (1982) 0.83
Argon laser iridotomy in incomplete peripheral iridectomy. Am J Ophthalmol (1975) 0.83
A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes. Am J Ophthalmol (1978) 0.82
Serum lysozyme in sarcoid uveitis. Am J Ophthalmol (1976) 0.82
Multiple recurrences of exudative retinal detachment in a patient with Vogt-Koyanagi-Harada disease. Retina (2000) 0.81
Novel imaging techniques for diabetic macular edema. Doc Ophthalmol (1999) 0.81
Risk factors for complications following traumatic hyphema. Arch Ophthalmol (2001) 0.80
Alteration of the blood-retinal barrier and vitreous in sickle cell retinopathy. Int Ophthalmol (1986) 0.80
Pars planitis and autoimmune endotheliopathy. Am J Ophthalmol (1987) 0.80
The eye in rheumatic disease. Bull Rheum Dis (1985) 0.80
Quadruple therapy for ocular toxoplasmosis. Can J Ophthalmol (1993) 0.80
Corticosteroids for reversal of myopic regression after photorefractive keratectomy. J Refract Surg (1995) 0.79
Quantification of macular ischaemia in sickle cell retinopathy. Br J Ophthalmol (1987) 0.79
Squamous cell carcinoma of the limbus with intraocular invasion. Ophthalmologica (1976) 0.79
Electroretinographic findings in sickle cell retinopathy. Arch Ophthalmol (1987) 0.79
Blood-retinal barriers in health and disease. Trans Ophthalmol Soc U K (1980) 0.78
Studies on the effects of osmotically active substances on the circulation and structure of the retina. II. Electron microscopical studies. Invest Ophthalmol (1967) 0.78
Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy. Diabetes (1986) 0.78
Vitreous fluorophotometry recordings in posterior segment disease. Graefes Arch Clin Exp Ophthalmol (1985) 0.78
HLA-B27, Klebsiella pneumoniae, and the relation to acute anterior uveitis. Invest Ophthalmol Vis Sci (1982) 0.78
Ocular fluorophotometry in the normal- and diabetic monkey. Exp Eye Res (1986) 0.78
Vitreous fluorophotometry studies in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol (1985) 0.78
Vitreous fluorophotometry in patients with fundus flavimaculatus. Arch Ophthalmol (1982) 0.78
Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy. Int Ophthalmol (1990) 0.78
Necrotizing scleritis following strabismus surgery for thyroid ophthalmopathy. J Pediatr Ophthalmol Strabismus (1989) 0.78
Findings typical of Susac's syndrome in a patient with scleroderma. Retina (1999) 0.77
Pharmacokinetic interpretation of vitreous fluorophotometry. Invest Ophthalmol Vis Sci (1983) 0.77
Vitreous fluorophotometry in optic nerve disease. Br J Ophthalmol (1982) 0.77
Anterior segment ischemia in Fuchs' heterochromic cyclitis. Arch Ophthalmol (1980) 0.77
Retinal blood flow in retinal detachment. Mod Probl Ophthalmol (1979) 0.77
Vitreous fluorophotometry evaluation of xenon photocoagulation. Invest Ophthalmol Vis Sci (1978) 0.77
Intraocular lens implants in patients with uveitis. Ophthalmology (1990) 0.77
The performance of a new commercial ocular fluorophotometer in the clinical environment. Graefes Arch Clin Exp Ophthalmol (1985) 0.77
Intraocular lysozyme in experimental uveitis in rabbits: aqueous and vitreous assay. Invest Ophthalmol (1976) 0.77
Type 1 and type 2 herpes simplex uvietis in immune rabbits: importance of pure virus preparation. Can J Ophthalmol (1975) 0.77